Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Focus Point Holdings BhdXKLS:0157 +0.97%70 3-Year EBITDA Growth Rate is 4.60% as of Jun. 2026, which is 69% below its 10-year median of 14.70. GuruFocus rates XKLS:0157 with a GF Score™ of 70/100 and a GF Value™ of RM0.66 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 689 Medical Devices & Instruments companies, Focus Point Holdings Bhd ranks worse than 56.46% on this metric.
During the past 12 months, Focus Point Holdings Bhd's average EBITDA Per Share Growth Rate was 11.40% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 4.60% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 19.80% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 29.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Focus Point Holdings Bhd was 47.00% per year. The lowest was -13.20% per year. And the median was 14.70% per year.
Focus Point Holdings Bhd (XKLS:0157) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Focus Point Holdings Bhd 3-Year EBITDA Growth Rate Related Terms
XKLS:0157 vs ISRG, BDX, RMD: 3-Year EBITDA Growth Rate Comparison
For the Medical Instruments & Supplies subindustry, Focus Point Holdings Bhd's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Focus Point Holdings Bhd 3-Year EBITDA Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Focus Point Holdings Bhd's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Focus Point Holdings Bhd's 3-Year EBITDA Growth Rate falls into.
Focus Point Holdings Bhd 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 4.60% mean?
Focus Point Holdings Bhd (XKLS:0157) has a 3-Year EBITDA Growth Rate of 4.60% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Focus Point Holdings Bhd and its competitors. This is 69% below median its historical median of 14.70. According to the industry distribution chart, Focus Point Holdings Bhd ranks #389 out of 689 companies in the Medical Devices & Instruments industry, placing it in the top 56.5%.
Is Focus Point Holdings Bhd's 3-Year EBITDA Growth Rate too high?
Focus Point Holdings Bhd's current 3-Year EBITDA Growth Rate of 4.60% is 69% below median its 10-year median of 14.70. The Medical Devices & Instruments industry median 3-Year EBITDA Growth Rate is 7.70. Focus Point Holdings Bhd's value of 4.60% is 40.3% below this industry median. Based on the distribution chart, Focus Point Holdings Bhd ranks #389 out of 689 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Focus Point Holdings Bhd has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Focus Point Holdings Bhd's 3-Year EBITDA Growth Rate compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Focus Point Holdings Bhd ranks #389 out of 689 companies for 3-Year EBITDA Growth Rate. This places Focus Point Holdings Bhd in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 7.70. Focus Point Holdings Bhd's value of 4.60% is 40.3% below this benchmark. While the company's 10-year median is 14.70 vs. the industry median of 7.70, Focus Point Holdings Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EBITDA Growth Rate among Medical Devices & Instruments companies is 7.70, based on 689 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Focus Point Holdings Bhd's current 3-Year EBITDA Growth Rate of 4.60% is 40.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Focus Point Holdings Bhd and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EBITDA Growth Rate is 7.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Focus Point Holdings Bhd's current 3-Year EBITDA Growth Rate is 4.60%, which is 69% below median its own 10-year median of 14.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Focus Point Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Focus Point Holdings Bhd (XKLS:0157) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.66, compared to a current price of RM0.52 — trading 21.2% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 4.60%, which is 69% below median its 10-year median of 14.70 and 40.3% below the Medical Devices & Instruments industry median of 7.70. Focus Point Holdings Bhd's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Focus Point Holdings Bhd (XKLS:0157), the current 3-Year EBITDA Growth Rate is 4.60% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Focus Point Holdings Bhd (XKLS:0157) Overvalued in 2026?
Based on GuruFocus' analysis, Focus Point Holdings Bhd stock appears to be undervalued.
The current stock price of RM0.52 is trading 21.2% below its estimated GF Value™ of RM0.66.
GuruFocus considers Focus Point Holdings Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0157:
3-Year EBITDA Growth Rate: 4.60% (69% below median its 10-year median of 14.70)
GF Value™: RM0.66 vs. price of RM0.52 (21.2% below fair value)
Industry Position: 40.3% below the Medical Devices & Instruments median (#389 of 689)
No single metric tells the full story. See the XKLS:0157 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Focus Point Holdings Bhd operates professional eye care centres, trading of eyewear and eye care products, investment holding, retail sale of other food products, management of franchised professional eye care centres, provision of medical eye care services, and operation of food and beverages business. The company's operating segments are the Optical segment and the Food and Beverages segment. The firm generates the majority of its revenue from the Optical segment, which is engaged in the retailing of optical and related products, including the management of franchised optical outlets. The food and beverages segment is into the provision of food and beverage services, including the management of franchised food and beverage outlets.
70GF Score
Get the complete analysis for XKLS:0157
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0157 has been successfully added to your 
